45 CFR § 180 compliance
F · 50
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
6,751
Insurances with rates
0
CPT / HCPCS codes
2,470
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1448 | TRILACICLIB DIHYDROCHLORIDE 300 MG IV SOLR | $1,822,128 | $546,638 | — | — | 0 |
| 4803324901 | Hc Ep Insj/Rplcmt Perm Dfb W/Trnsvns Lds 1/Dual Chmbr | $217,199 | $65,160 | — | — | 0 |
| J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $158,340 | $47,502 | — | — | 0 |
| 4803326201 | Hc Ep Rmvl Impltbl Dfb Plse Gen W/Repl Plse Gen 1 Lead | $130,376 | $39,113 | — | — | 0 |
| 4803326301 | Hc Ep Rmvl Impltbl Dfb Plse Gen W/Rplcmt Plse Gen 2 Ld | $130,376 | $39,113 | — | — | 0 |
| 4803326401 | Hc Ep Rmvl Impltbl Dfb Pls Gen W/Rplcmt Pls Gen Mlt Ld | $130,376 | $39,113 | — | — | 0 |
| J2507 | PEGLOTICASE 8 MG/ML IV SOLN | $113,520 | $34,056 | — | — | 0 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $103,668 | $31,100 | — | — | 0 |
| J3357 | USTEKINUMAB 90 MG/ML SC SOSY | $103,519 | $31,056 | — | — | 0 |
| 4803327001 | Hc Ep Ins/Rplcmnt Perm Subq Impltbl Dfb W/Subq Eltrd | $98,330 | $29,499 | — | — | 0 |
| 4813328901 | Hc Impl Pressure Sensor W/Angio | $91,123 | $27,337 | — | — | 0 |
| J9266 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $90,305 | $27,092 | — | — | 0 |
| 4813722701 | Hc Fem/Popl Revasc Stent & Ather | $81,555 | $24,467 | — | — | 0 |
| 4813723101 | Hc Tib/Per Revas Pta/Stent/Ather | $81,555 | $24,467 | — | — | 0 |
| 278C1767S1 | Sentiva Generator | $77,828 | $23,348 | — | — | 0 |
| J2327 | RISANKIZUMAB-RZAA 360 MG/2.4ML SC SOCT | $74,188 | $22,256 | — | — | 0 |
| 4803320801 | Hc Ep Inser Hart Pacer Xvenous Atr/Ventr | $73,135 | $21,941 | — | — | 0 |
| 4810238T01 | Hc Trluml Perip Athrc Iliac Art | $72,339 | $21,702 | — | — | 0 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $72,255 | $21,677 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $71,225 | $21,368 | — | — | 0 |
| 4803322401 | Hc Ep Insj Eltrd Car Ven Sys Attch Prev Pm/Dfb Pls Gen | $70,302 | $21,091 | — | — | 0 |
| 4803322501 | Hc Ep Insj Eltrd Car Ven Sys Tm Insj Dfb/Pm Pls Gen | $70,302 | $21,091 | — | — | 0 |
| 4819358001 | Hc Cath Perc Clos,Cong Interatrial Commun W/Impl | $64,665 | $19,400 | — | — | 0 |
| 3337737201 | Hc Srs Linear Based 1 Session | $63,598 | $19,079 | — | — | 0 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $61,644 | $18,493 | — | — | 0 |
| 4803320601 | Hc Ep Inser Hart Pacer Xvenous Atrial | $59,799 | $17,940 | — | — | 0 |
| 4803320701 | Hc Ep Inser Hart Pacer Xvenous Ventr | $59,799 | $17,940 | — | — | 0 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $57,845 | $17,354 | — | — | 0 |
| 4809365401 | Hc Ep Ephys Eval W/Ablation Ventricular Tachycardia | $54,673 | $16,402 | — | — | 0 |
| J9043 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $54,669 | $16,401 | — | — | 0 |
| 4803322101 | Hc Ep Ins Pacemaker Pulse Gen Only W/Exist Mult Leads | $54,187 | $16,256 | — | — | 0 |
| 4809365301 | Hc Ep Ephys Eval W/Ablation Supravent Arrhythmia | $52,166 | $15,650 | — | — | 0 |
| 4809365601 | Hc Ep Ephys Evl Trnsptl Tx Atrial Fib Isolat Pulm Vein | $52,166 | $15,650 | — | — | 0 |
| 278C2624S1 | Cariomem Pa Sensor And Delivery System | $50,525 | $15,158 | — | — | 0 |
| 4813723501 | Hc Tib/Per Revas Pta/Stent/Ather Add | $49,432 | $14,830 | — | — | 0 |
| 481C976601 | Hc Revasc Intra Lithotrip-Ather | $47,989 | $14,397 | — | — | 0 |
| 481C977401 | Hc Revasc Lithotr-Ather Tib/Per | $47,989 | $14,397 | — | — | 0 |
| 481C976501 | Hc Revasc Intra Lithotrip-Stent | $47,899 | $14,370 | — | — | 0 |
| 481C976701 | Hc Revasc Lithotrip-Stent-Ather | $47,899 | $14,370 | — | — | 0 |
| 4813327401 | Hc Tcat Insj/Rpl Perm Ldls Pm | $47,686 | $14,306 | — | — | 0 |
| 3613722601 | Hc Revascularize Fem/Pop Artery,Angioplasty/Stent | $47,090 | $14,127 | — | — | 0 |
| 4813722501 | Hc Fem/Popl Revas Pta/Ather | $47,090 | $14,127 | — | — | 0 |
| 4813722601 | Hc Fem/Popl Revasc Pta/Stent | $47,090 | $14,127 | — | — | 0 |
| 4813722901 | Hc Tib/Per Revas Pta/Ather | $47,090 | $14,127 | — | — | 0 |
| 4813723001 | Hc Tib/Per Revasc Pta/Stent | $47,090 | $14,127 | — | — | 0 |
| 4813723301 | Hc Tib/Per Revas Pta/Ather Add-On | $47,090 | $14,127 | — | — | 0 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $45,124 | $13,537 | — | — | 0 |
| 3603330501 | Hc Repair Of Heart Wound | $45,000 | $13,500 | — | — | 0 |
| 278C1882S1 | Defib Cardiac Quadra Assura Mp_Icd_Pr Cd3369-40Q | $44,359 | $13,308 | — | — | 0 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $44,165 | $13,250 | — | — | 0 |
Showing top 50 of 6,751 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.